QA: Agile Therapeutics INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001261249_2015_Agile_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001261249, Agile Therapeutics INC

  xvar xval
0 AssetsCurrent 40,985,916
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 12,046,267
3 remainder_Assets 1,794,043
4 LiabilitiesCurrent 8,992,521
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,150,512
9 ResearchAndDevelopmentExpense 13,364,704
10 remainder_Expenses -2,435,185
11 remainder_Revenues 0
12 remainder_NetIncome 2,563
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 54,826,226
1 Liabilities 8,992,521
2 Expenses 16,080,031
3 Revenues 0
4 StockholdersEquity 45,833,705
5 NetIncome -16,077,468
6 ComprehensiveNetIncome -16,077,468
7 BaseVar 39,950,670
8 EconomicCapitalRatiobeforeLimitedLiability 2.63
9 EconomicCapitalRatio 3.44

Edgar->Model Mapping

Feature Distribution